I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78%
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InDex Pharmaceuticals Holding AB
Net Change in Cash Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Net Change in Cash
kr456.7m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Net Change in Cash
-kr68.9m
CAGR 3-Years
55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Net Change in Cash
kr1.9B
CAGR 3-Years
112%
CAGR 5-Years
87%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Net Change in Cash
-kr27.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Net Change in Cash
-kr141.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Net Change in Cash
-kr65m
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Net Change in Cash?
Net Change in Cash
456.7m SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Net Change in Cash amounts to 456.7m SEK.

What is InDex Pharmaceuticals Holding AB's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
4%

Over the last year, the Net Change in Cash growth was 2 602%. The average annual Net Change in Cash growth rates for InDex Pharmaceuticals Holding AB have been 4% over the past three years .

Back to Top